Trade Summary

3 days ago, Delaet Ingrid, serving as Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 14,571 shares at $178.65 per share, for a total transaction value of $2,603,111.99. Following this transaction, Delaet Ingrid now holds 16,225 shares of NBIX.

This sale represents a 47.31% decrease in Delaet Ingrid's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 7, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 9, 2026 at 6:41 PM ET, 2 days after the trade was made.

NEUROCRINE BIOSCIENCES INC operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.